NCT00539331View on ClinicalTrials.gov

Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

AZD2171

oral tablet

DRUG

Paclitaxel

intravenous infusion

DRUG

Carboplatin

intravenous injection

Trial Locations (2)

Unknown

Research Site, Osaka

Research Site, Tokyo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00539331 - Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients | Biotech Hunter | Biotech Hunter